IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Date	Title
07/03/2008	Ziagen;Kivexa;Trizivir (abacavir sulfate)-Important Safety Information from GlaxoSmithKline on genetic screening
01/09/2008	Volume 9A of The Rules Governing Medicinal Products in the European Union
06/05/2008	Velcade (bortezomib)-Important Safety Information from Janssen-Cilag as approved by the IMB
13/03/2008	Tyverb (lapatinib)-Important Safety Information from GlaxoSmithKline regarding possible hepatotoxicity with this product
26/05/2008	Tysabri (natalizumab)-Important Safety Information from Elan/Biogen Idec concerning serious hepatic reactions with Tysabri
18/08/2008	Tysabri (natalizumab)-Important Safety Information from Elan/Biogen Idec as approved by the IMB
15/02/2008	Traditional Herbal Medicines Products Registration Scheme - Information Session
01/08/2008	Thalidomide Pharmion-Important Safety Information from Celgene as approved by the IMB
30/09/2008	Terms of reference and rules of procedure of the Clinical Trials Subcommittee
31/01/2008	Suspected Adverse Reactions to Veterinary Medicinal Products 2006 - 2007
08/07/2008	Revlimid (lenalidomide)-Important Safety Information from Celgene as approved by the IMB
18/06/2008	Reporting Serious Adverse Reactions (SARs) and Serious Adverse Events (SAEs) associated with Human Tissues
22/09/2008	Relistor (methylnaltrexone bromide)-Important Safety Information from Wyeth as approved by the IMB
04/11/2008	Raptiva (efalizumab)-Important Safety Information from Merck Serono on the association of efalizumab with PML
25/02/2008	Provigil (modafinil)-Important Safety Information from Cephalon as approved by the IMB
02/12/2008	Prograf & Advagraf (tacrolimus)-Important Safety Information from Astellas Pharma following approval by the IMB
03/10/2008	Perfalgan (paracetamol)-Important Safety Notice from Bristol-Myers Squibb regarding hepatic toxicity
07/02/2008	Notification of Withdrawal of Authorisations or Certificates for Veterinary Medicines
11/06/2008	Neupro (rotigotine)-Important Information from UCB (Pharma) on the recall of certain packs
16/12/2008	Medical Devices Newsletter No. 24 - December 2008